⸺ Celvora
Wolverine Pre-filled Pen (Alluvi)
Alluvi Healthcare BPC-157 + TB-500 recovery blend as a ready-to-use pre-filled pen. Research use only.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About Wolverine Pre-filled Pen (Alluvi)
Combined BPC-157 and TB-500 pre-filled pen by Alluvi Healthcare. Ready-to-use.
⸺ Mechanism of Action
How it works
BPC-157 modulates growth-factor and nitric-oxide signalling; TB-500 regulates actin dynamics and cell migration.
⸺ Research
Areas of study
Soft-tissue repair
Animal models describe improved tendon, ligament and muscle repair.
Gastrointestinal protection
Rodent studies show protective effects on gastric lining.
⸺ Details
Specification
- CAS
- Blend — BPC-157 / TB-500
- Intended use
- Research use only. Pre-filled pen.
- Storage
- Refrigerate 2–8°C.
- Solubility
- Pre-filled solution.
- Shelf life
- Refer to printed expiry.
- Handling
- Sterile technique.
You might also research
View all →
R3ta
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
T1rz
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.